17-Feb-2020 | Zion Market Research
Zion Market Research has published a new report titled “Hypopigmentation Disorder Treatment Market by treatment (topical drugs, laser, chemical peels, microdermabrasion and others (phototherapy, etc.).), disease indication (Vitiligo, albinism and others), and end user (hospitals, aesthetic clinics & dermatology centers, and others): Global Industry Perspective, Comprehensive Analysis and Forecast, 2019 – 2025”.
According to the report, global demand for Hypopigmentation Disorder Treatment market was valued at approximately USD 454.32 million in 2018, and is expected to generate revenue of around USD 665.4 million by end of 2025, growing at a CAGR of around 5.64% between 2019 and 2025.
Hypopigmentation is the lack of skin pigment, or light. It can happen or be placed throughout the body. In localized hypopigmentation several patches or areas on the skin can appear white. The size and shape of the patch can vary a great deal. Either in individuals with hypopigmentation there is a decrease in melanin itself. A drop in amino acid tyrosine may also induce hypopigmentation. Melanocytes release tyrosine to produce melanin. Hypopigmentation might occur in people of all races, but it may be more noticeable in people with darker skin due to the dissimilarity between natural skin color and white patches. Many different causes cause the hypopigmentation. The disorder most often arises as a result of damage or trauma to the skin. Blisters, burns and infections all can cause damage to the skin and cause hypopigmentation. Cosmetic skin treatments such as chemical or laser peels can also induce hypopigmentation when the procedure is done incorrectly.
Browse the full “Hypopigmentation Disorder Treatment Market by treatment (topical drugs, laser, chemical peels, microdermabrasion and others (phototherapy, etc.).), disease indication (Vitiligo, albinism and others), and end user (hospitals, aesthetic clinics & dermatology centers, and others): Global Industry Perspective, Comprehensive Analysis and Forecast, 2019 - 2025.” Report at https://www.zionmarketresearch.com/report/hypopigmentation-disorder-treatment-market
Growing lifestyle spending as well as increasing awareness among people drives the growth of the pigmentation disorders treatment market. Additionally, the increasing occurrence of skin disorders is driving the growth of demand for hypopigmentation disorder treatment. It is expected to improve the demand for the treatment of hypopigmentation disorders by increasing aging population and rising people concerned with improving the affected skin. The growing demand for pigmentation disorder treatment is coupled with the increasing number of people affected by pigmentation disorders, which in turn triggers the growth of the pigmentation disorder treatment market. The high cost of treatment, however, may impede market growth for treating pigmentation disorders.
The market for Hypopigmentation Disorder Treatment is segmented based on treatment, disease indication, end user, and region. Based on treatment, the market is segmented into topical drugs, laser, chemical peels, microdermabrasion and others (phototherapy, etc.). The study projects that the topical drugs will dominate the hypopigmentation disorder treatment market owing to the upsurge in the number of patients with the hypopigmentation disorders visiting to the dermatologists and majorly, the topical drugs are being prescribed to the patients.
Based on disease indication, the market is segmented into vitiligo, albinism, and others. Vitiligo segment is expected to dominate the market due to the more number of patients being treated for vitiligo. Based on end user, the market is segmented into hospitals, aesthetic clinics & dermatology centers, and others.
Regional segmentation includes the current and forecast demand for Asia Pacific, North America, Latin America, Europe, and Middle East & Africa with its further bifurcation into major countries. Asia-Pacific dominated the treatment market for the pigmentation deficiency. Growing population and increased awareness of skin disorders are driving growth in the area's demand for treating pigmentation disorder. Increasing disposable income and lifestyle changes have resulted in increased demand for treatment for pigmentation disorders.
Some of the players included in Hypopigmentation Disorder Treatment market are Allergan, Alvogen, Episciences Inc., Obagi Cosmeceuticals LLC, Pierre Fabre, Rxi Pharmaceutical Corporation and SkinCeuticals amongst others.
The report segments the Hypopigmentation Disorder Treatment market as follows:
Global Hypopigmentation Disorder Treatment Market: Treatment Segment Analysis
Global Hypopigmentation Disorder Treatment Market: Disease Indication Segment Analysis
Global Hypopigmentation Disorder Treatment Market: End user Segment Analysis
Global Hypopigmentation Disorder Treatment Market: Regional Segment Analysis
Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.
Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651